These 4 Undervalued Stocks Have MASSIVE Upside Potential Right Now

The more stocks make new highs, the more headlines get generated about stocks being overpriced, but don't let that suck you into believing that every stock is overinflated. In fact, if you look in the right places, you can still find stocks that are downright cheap. Luckily, you don't need to go on that search. I've already done it for you. Today, I will share with you four stocks that are not only attractively priced, but also have healthy growth prospects that help propel shares higher and higher. Be sure to stick around as I have saved the best stock for last. Yet, there is no shame in the game for our first stock, which is Century Aluminum with the symbol of CENX. This is the largest producer of primary aluminum in the United States with smelters here and in Iceland turning out the metal that goes into everything from cars to power grids to defense hardware. Now, before I get ahead of myself, let me tell you who I am. I'm Steve Wrightmeister, but everyone calls me Wrighty. I've been investing for over 40 years and currently a partner at wallstreetzen.com where our quant rating system identify stocks with the highest likelihood to outperform the market. And if you like discovering undervalued gems, then please hit that like button as it tells me to record more videos along these lines in the future. Okay, let's get back to today's four undervalued stocks. Now, here's why Century Aluminum is interesting right now. Tariffs have put a wall around domestic metal producers and Century sits right behind that wall. That domestic protection has flowed straight into their quarterly results. Even better is the forecast for 51% earnings growth in the year ahead. That is four times faster than industry peers. Now, for as much as you should be impressed by the growth story, the value story is even more attractive. That shows up in their rock-bottom PEG ratio of just 0.16. Now, let's remember that the average stock these days trade for PEG ratio of 1.5. So, we are talking about a truly dirt-cheap valuation for these shares. Here's another thing I like. Shares were on a nice momentum run this past year followed by an extended run of profit-taking where it has pulled back about 30% from the highs. That buy-the-dip quality certainly adds to the appeal of shares at this time. Wall Street is unanimously bullish with strong buy recommendations across the board. This includes an average fair value price target coming for 80% upside in the year ahead. Even better is the street high target price which comes from Lucas Pipes of B. Riley Securities. Now, this matters because Lucas ranks in the top 3% of all analysts based upon his actual stock picking performance. His target price implies 95% upside potential in the year ahead. Gladly, the Zen Ratings Quant Model agrees with this bullish premise. Remember, our system weighs each stock against 115 different fundamental and technical factors. Results are then distilled down into an intuitive letter grade of A through F. Just like in school, you want a report card filled with A's and B's because lower grades are going to get you grounded. Century scores a very solid B rating which amounts to a buy recommendation. Now, note that our elite A ratings are reserved for just the top 5% of all stocks. Century is knocking on the door in the top 6%. So, maybe better stated that this is an A- minus stock. All right, beyond the overall Zen Rating, we also provide seven underlying component grades that can give us some clues about the unique strengths and weaknesses of any stock. So, let's take a look what that means for Century. Financial strength lands in the top 4% of all stocks which is pretty hard to do for an Industrials and Metals company. Value even better in the top 3%. This is based upon 21 different measures of value, so not just the PEG ratio that I shared with you. And the standout grade is growth in the top 2% of all stocks tracked. This is a trifecta of the three most important component grades. All is positive in Century's camp. Safety is the one weak spot worth noting. That's a typical trade-off with a cyclical metals company that will lead to more volatile shares. But consider the big picture here. We have the tariff protection for domestic aluminum production leading to outside growth potential. Now, add on top that the Wall Street support, not just the strong buy reviews, but the the fair value target, and the stellar review from the Zen Ratings Quant Model, this gives us a great value stock to kick off today's video. Quick aside before I continue with the other the If you enjoy discovering uh companies aligned with current events like this, then the best thing you can do right now is sign up for my next live training session this coming Monday. The focus is on timely market insights plus my top picks. Now, it's totally free, but you do need to sign up. And you can do that now. Join me this coming Monday. Just go to wallstreetzen.com/live. Let's get back to the undervalued stocks, which brings us to our second pick in Riley Exploration uh Permian with a symbol of REPX. Now, this is an independent oil and gas producer working the Permian Basin Texas and New Mexico. And as you probably already know, the Permian is the most productive oil patch in the country. Here's why it should be on your radar right now. Riley recently raised its full-year production guidance by 30% year-over-year growth. When an energy company is telling you it's pumping out more oil and lifting its own targets, that is a business with a strong tailwind at its back. And it's priced like nobody's paying attention. Riley's PEG ratio is not as obscenely low as our last stock, but still very, very attractive. It's just 0.46. That is 2/3 lower than the average stock these days. And unlike most energy exploration companies, they also serve up a surprisingly large dividend. We are talking about a 4.2% dividend yield that certainly helps fatten your portfolio. And just for clarity, they have been increasing that dividend for the past 6 years. So, if more growth is in the forecast, then expect the current dividend to be raised again and again. Wall Street is once again firmly bullish with all analysts uh in the strong buy category. That includes the analyst uh Sergey Perekhozhuk. I hope I said that right. A freedom broker who ranks in the top 12% of all analysts we track. His fair value price target suggests the stock could see nearly 40% more upside in the coming year. Now, Riley leaps into the elite A rating in our fundamental model. Note that the A rating stocks have historically outperformed the S&P 500 by nearly 3 to 1 over the past two decades. And this would be a good moment to remind you that the Zen ratings are updated daily on wallstreetzen.com. So, for the most up-to-date ratings on this or any stock, be sure to check out our quote pages and be sure to bookmark our website for all your future visits. All right, getting back to the component grades which underscore the attractive A rating overall. We have momentum coming in the top 20% of all stocks. We have our financials in the top 14%. Growth is right there with it in the top 14%. The AI factor grade, which measure how likely a stock is to outperform based upon patterns in the data, lands in the top 8%. Let's call that a timeliness factor. And the standout grade, as it should be in a video about value, is yes, they are in the top 2% of all stocks tracked for the value category. The risk is obvious for Riley, which is the same as any energy stock that is affected by where oil and gas prices go in the future. That risk is greatly cushioned by their massive increase in production, plus the robust dividend yield, plus the ample value proposition. Plain and simple, if you're going to have energy exposure in your portfolio, you'll be hard-pressed to do better than this one. Quick ask before we move on to more stocks, if you're getting value out of this video, then take a second to subscribe and hit that notification bell. That's because I publish data-driven stock analysis like this frequently, and I'd hate for you to miss any of my next videos. Okay, our third value stock today is 8x8 with the symbol EGHT. They run a cloud communications platform, the phone systems, contact centers, and messaging that businesses run on, all built into one AI-powered system. That's pretty interesting on the surface, but the reason shares are woefully underpriced is the company was not profitable for a long period of time, with the turnaround just starting to take shape recently. The turnaround is not an accident. The fastest growing part of the business is the usage-based recurring revenue side, the communications APIs and AI tools that companies plug and pay for as they scale up. That piece grew more than 70% over last year, and it's quietly reshaping the company into something the market still has not fully priced into shares just yet. Let's talk about value. On a discounted cash flow basis, 8x8 has nearly 100% upside potential to reach its fair value target. The PEG value equation is even more stark. The reading of 0.3 means that shares would need to rise fivefold to attain the valuation of the average stock. Now, you put the two together and it it says the stock is downright dirt cheap. This is a small company, only 300 million market cap. So, Wall Street coverage is modest, but still potent. Both the analysts on board are pounding the table with strong buy recommendations. Even more telling are their fair value price targets pointing to 50 to 60% upside potential in just the coming year, much more in the years beyond that. Our Zen ratings quant model is emphatically on board. 8x8 earns that A rating strong buy recommendation. That's because it lands in the top 2% of all stocks we track owing to its truly standout fundamental profile. As you might expect, the underlying component grades reveal several key areas of strength. Financials comes in the top 22% of all stocks, likely that will continue to improve as the turnaround unfolds. Safety in the top 16% of all stocks, growth top 11%. This bodes well for more earnings beats ahead and the AI timeliness grades in the top 7%. And yes, value, as it should be, is in the top 1% of all stocks we track. This is a great roster for a stock in an undervalued stocks video. A rare mix of deep value, strong growth, and solid fundamentals. Now, turnarounds are often one of the best reward profiles for investors. This is because they typically are undervalued that also lead to outsize growth. The risk, of course, is if the turnaround fizzles out. But as long as the turnaround stays on track, then there is a lot of reason to believe 8x8 will deliver outsize returns in the months and years ahead for shareholders. Before we get to that last stock, one quick thing. If you want to stay one step ahead of the market, then join me live every Monday. That's when I share my updated market outlook and trading plan to outperform. It's also when I unveil my trade of the week based upon our proven R quant model and my greater than 40 years of investing experience. Now, it's a free event, but you do need to register. Just go to wallstreetzen.com/live or click the link in the description down below or scan the QR code on the screen wherever it is. Just pause the video for a moment to sign up. I'll be patient and wait for you. Then I look forward to seeing you there on Monday. As I like to do, I've been saving the most interesting stock for last. That brings us to another turnaround story in Arcturus Therapeutics with a symbol of ARQT. Say that 10 times fast. They are a dermatology company built around one fast-growing flagship treatment for chronic inflammatory skin conditions. Now, here is why the timing matters. Arcturus just crossed over into profitability and has filed to expand the label on its lead drug into new conditions, which means a bigger market opportunity ahead. A company hitting profitability right as its addressable market widens is a kind of inflection point that tends to keep a stock price moving higher and often a hell of a lot higher. But look at the earnings trajectory. Year over year, they had nasty losses, but quarter after quarter, those losses began to shrink. And more recently, it crossed over into profitable territory. This is what a turnaround looks like in real time. What matters most is the growth that lies ahead. And right now, Wall Street experts predict earnings will rise 108% a year. Many many times faster than their biotech peers. Even still, the 1.1 PEG ratio still points to being nicely undervalued. Now, obviously, this stock leans more hardly on the stunning growth story, even if it's not as obscenely undervalued as the previous picks. Wall Street is leaning into these shares with all six covering analysts in the buy or strong buy category. Now, the value story shows up once again in all their fair value price targets. The average target points to 45% upside in the year ahead. But uh Serge Balanger of Needham, who ranks in the top 2% of all analysts tracked based upon his actual stock picking performance, he sees 60% upside from current levels. He's the kind of guy when he talks, people are wise to listen. Now, our Zen rings puts a bow on the gift wrapping for Arcutis. This is another elite A-rated stock. This is based upon them scoring in the top 2% of all stocks after that full 115 fundamental and technical factor review. Let's see what's behind those glittering fundamentals by taking a look at the key component grades. The AI factor, the timeliness grade lands in the top 21% of all stocks tracked. Value is top 18%. That's based upon 21 different measures of value. Financials in the top 14%. It's a well-run operation. Growth in the top 10%. Healthy, consistent growth is now taking shape. And the standout grade is sentiment in the top 6% of all stocks tracked. This tells us the smart money investors are already leaning into shares. The main risk is what you would expect. So, what happens if they don't find broader approval for the current drug leaving them as a one-trick pony. Yet, there is obviously a reason why so many Wall Street experts are committed to these shares and predicting such outsized growth. The Zen rings confirms their fundamental prowess. Now, add it all up and it would appear the reward greatly outweighs the risk at this time. So, there you have it. Four undervalued stocks the market has completely overlooked, but you definitely shouldn't. These are the kinds of setups that don't stay overlooked forever. So, if any of these stocks speak to you, it is wise to do your homework sooner rather than later. That's a good time to remind you that Zen rings are updated every day for free on our quote pages at wallstreetzen.com. So, be sure to check them out before making any buy, hold, or sell decisions on any stocks that interest you. So, now is a good time to bookmark the site on your browser for all your future research. Now, I want to hear from you. Which of these four stocks do you like the most? And are there any other undervalued names I didn't mention that are worth watching right now? Please share it with our community in the comment section below. If you want to see more tickers that have tremendous upside potential, then I suggest you check out the video that's popping up on your screen right now.